Hemophilia A is a condition that keeps your blood from clotting the way it should. That means your body has problems stopping bleeding, both outside and inside your body. Your condition can be treated ...
Factor VIII inhibitors are IgG alloantibodies that arise during replacement therapy in 25 to 50 percent of patients with severe hemophilia A. The hydrolysis of factor VIII by anti–factor VIII ...
Active ingredient: Antihemophilic Factor (recombinant): nominally 250 IU, 500 IU, 1,000 IU, or 2,000 IU per vial; powder for IV infusion after reconstitution; plasma/ albumin-free; preservative-free; ...
People with severe hemophilia A are at risk for prolonged bleeding events that can cause serious complications. To prevent these bleeding events, most people with this condition get injections of a ...
AFSTYLA ®, Antihemophilic Factor (Recombinant), Single Chain, is contraindicated in patients who have had life-threatening hypersensitivity reactions to AFSTYLA or its excipients, or to hamster ...
Baroness Campbell, whose husband caught HIV after taking medicine prescribed by the NHS, wants the Government to deliver justice for victims Joe Pinkstone joined The Telegraph in 2021. He is ...
Various hematopoietic cell lines were transduced with pRRL-PPT-CMV-FVIII-W-SIN at a multiplicity of infection (MOI) of 10. After 6 days, normalized transduction rates were determined by real-time PCR ...
Many hemophilia drugs have used the number connection, but the Brand Institute went a step further with Altuviiio. (Getty stock photo) Sanofi and the Brand Institute have raised the bar in drug naming ...
People with hemophilia A bleed and bruise easily, and their blood takes a long time to form clots. Hemophilia A is a rare, serious condition that has no cure, but is treatable. Hemophilia A is most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results